CHUK
Inhibitor of nuclear factor kappa-B kinase subunit alpha
Also known as: IkBKA, IKK-alpha, IKK1, IKKA, IKKA_HUMAN, NFKBIKA, TCF16
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15111
- Gene
- CHUK
- Ensembl
- ENSG00000213341
- Chromosome
- 10
- Canonical length
- 745 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the serine/threonine protein kinase family. The encoded protein, a component of a cytokine-activated protein complex that is an inhibitor of the essential transcription factor NF-kappa-B complex, phosphorylates sites that trigger the degradation of the inhibitor via the ubiquination pathway, thereby activating the transcription factor. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
745 residues, UniProt reviewed canonical sequence.
>O15111|CHUK
1 MERPPGLRPG AGGPWEMRER LGTGGFGNVC LYQHRELDLK IAIKSCRLEL STKNRERWCH
61 EIQIMKKLNH ANVVKACDVP EELNILIHDV PLLAMEYCSG GDLRKLLNKP ENCCGLKESQ
121 ILSLLSDIGS GIRYLHENKI IHRDLKPENI VLQDVGGKII HKIIDLGYAK DVDQGSLCTS
181 FVGTLQYLAP ELFENKPYTA TVDYWSFGTM VFECIAGYRP FLHHLQPFTW HEKIKKKDPK
241 CIFACEEMSG EVRFSSHLPQ PNSLCSLVVE PMENWLQLML NWDPQQRGGP VDLTLKQPRC
301 FVLMDHILNL KIVHILNMTS AKIISFLLPP DESLHSLQSR IERETGINTG SQELLSETGI
361 SLDPRKPASQ CVLDGVRGCD SYMVYLFDKS KTVYEGPFAS RSLSDCVNYI VQDSKIQLPI
421 IQLRKVWAEA VHYVSGLKED YSRLFQGQRA AMLSLLRYNA NLTKMKNTLI SASQQLKAKL
481 EFFHKSIQLD LERYSEQMTY GISSEKMLKA WKEMEEKAIH YAEVGVIGYL EDQIMSLHAE
541 IMELQKSPYG RRQGDLMESL EQRAIDLYKQ LKHRPSDHSY SDSTEMVKII VHTVQSQDRV
601 LKELFGHLSK LLGCKQKIID LLPKVEVALS NIKEADNTVM FMQGKRQKEI WHLLKIACTQ
661 SSARSLVGSS LEGAVTPQTS AWLPPTSAEH DHSLSCVVTP QDGETSAQMI EENLNCLGHL
721 STIIHEANEE QGNSMMNLDW SWLTELocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHUK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- kidney: 20 nTPM
- bone marrow: 19 nTPM
- liver: 16 nTPM
- skeletal muscle: 13 nTPM
- thymus: 13 nTPM
- parathyroid gland: 13 nTPM
Single-cell type
- neutrophils: 141 nCPM
- neutrophil progenitors: 84 nCPM
- monocyte progenitors: 49 nCPM
- erythrocyte progenitors: 46 nCPM
- early primary spermatocytes: 44 nCPM
- corticotrophs: 42 nCPM
Immune cell
- neutrophil: 2.8 nTPM
- eosinophil: 2.1 nTPM
- intermediate monocyte: 1.9 nTPM
- NK-cell: 1.8 nTPM
- memory B-cell: 1.6 nTPM
- memory CD8 T-cell: 1.6 nTPM
Brain region
- hypothalamus: 16 nTPM
- white matter: 15 nTPM
- choroid plexus: 14 nTPM
- spinal cord: 13 nTPM
- basal ganglia: 13 nTPM
- medulla oblongata: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHUK.
Disease | AllUniProt
Conditions CHUK is implicated in, by any mechanism.
- Cocoon syndrome (COCOS) MIM:613630
- Bartsocas-Papas syndrome 2 (BPS2) MIM:619339
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 290 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cocoon syndrome
- Bartsocas-Papas syndrome 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 2.78
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- autophagy
- canonical NF-kappaB signal transduction
- cellular response to tumor necrosis factor
- cellular response to virus
- immune response
- inflammatory response
- innate immune response
- integrin-mediated signaling pathway
- negative regulation of autophagy
- negative regulation of NF-kappaB transcription factor activity
- non-canonical NF-kappaB signal transduction
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of interferon-alpha production
- positive regulation of NF-kappaB transcription factor activity
- positive regulation of transcription by RNA polymerase II
- response to amino acid
- response to cholecystokinin
- response to hydroperoxide
- response to toxic substance
- response to virus
- response to xenobiotic stimulus
- skeletal muscle contraction
- striated muscle cell differentiation
- toll-like receptor 4 signaling pathway
- tumor necrosis factor-mediated signaling pathway
- response to acetate
Molecular functions
- ATP binding
- IkappaB kinase activity
- protein heterodimerization activity
- protein homodimerization activity
- protein kinase activity
- protein serine/threonine kinase activity
- protein-containing complex binding
- scaffold protein binding
- transferrin receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- I-kappa-kinase-beta NEMO binding domain
- IKBKB, scaffold dimerization domain
- IKBKB, scaffold dimerization domain superfamily
- Inhibitor of nuclear factor kappa-B kinase
- Protein kinase domain
- I-kappa-kinase-beta NEMO binding domain
- IQBAL scaffold dimerization domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHUK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHUK as an antibody target. Whether an autoantibody or antibody against CHUK could matter depends on whether native CHUK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHUK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHUK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...